| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |